The University of Southampton
University of Southampton Institutional Repository

mTOR Signalling in Health and Disease

mTOR Signalling in Health and Disease
mTOR Signalling in Health and Disease
The TOR (target of rapamycin) proteins are found in all eukaryotes. TOR has a protein kinase domain, as well as other domains through which it interacts with partner proteins to form at least two types of multiprotein complex, TORC1 and TORC2 (TOR complexes 1 and 2). Rapamycin, an antibiotic and immunosuppressant, inhibits functions of TORC1. Use of this drug has revealed roles for TORC1 and its mammalian counterpart, mTORC1, in promoting many anabolic processes. mTORC1 signalling is activated by growth factors and nutrients. It is highly active in many cancers and plays a role in tumorigenesis and in other diseases. Much less is known so far about the functions and regulation of (m)TORC2. The goal of this meeting was to bring together researchers studying the roles of mTORC1/2 in normal cell and animal physiology in diverse systems, as well as scientists exploring the therapeutic value of inhibiting mTOR (mammalian TOR) signalling.
mammalian target of rapamycin (mtor), protein kinase, rapamycin, signalling, target of rapamycin (tor), target of rapamycin complex (torc)
0300-5127
431-436
Proud, Christopher G.
59dabfc8-4b44-4be8-a17f-578a58550cb3
Proud, Christopher G.
59dabfc8-4b44-4be8-a17f-578a58550cb3

Proud, Christopher G. (2011) mTOR Signalling in Health and Disease. Biochemical Society Transactions, 39 (2), 431-436. (doi:10.1042/BST0390431). (PMID:21428914)

Record type: Article

Abstract

The TOR (target of rapamycin) proteins are found in all eukaryotes. TOR has a protein kinase domain, as well as other domains through which it interacts with partner proteins to form at least two types of multiprotein complex, TORC1 and TORC2 (TOR complexes 1 and 2). Rapamycin, an antibiotic and immunosuppressant, inhibits functions of TORC1. Use of this drug has revealed roles for TORC1 and its mammalian counterpart, mTORC1, in promoting many anabolic processes. mTORC1 signalling is activated by growth factors and nutrients. It is highly active in many cancers and plays a role in tumorigenesis and in other diseases. Much less is known so far about the functions and regulation of (m)TORC2. The goal of this meeting was to bring together researchers studying the roles of mTORC1/2 in normal cell and animal physiology in diverse systems, as well as scientists exploring the therapeutic value of inhibiting mTOR (mammalian TOR) signalling.

Full text not available from this repository.

More information

Published date: April 2011
Keywords: mammalian target of rapamycin (mtor), protein kinase, rapamycin, signalling, target of rapamycin (tor), target of rapamycin complex (torc)
Organisations: Centre for Biological Sciences

Identifiers

Local EPrints ID: 350250
URI: http://eprints.soton.ac.uk/id/eprint/350250
ISSN: 0300-5127
PURE UUID: 9d811f6c-3edc-4d5f-a8fe-161c8a7734ef

Catalogue record

Date deposited: 20 Mar 2013 12:43
Last modified: 16 Jul 2019 21:40

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×